Article Details
Retrieved on: 2018-01-26 11:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Medtech startup Axio Biosolutions raised $7.4 million funding in Series B round from Ratan Tata's RNT Capital, which will be used for expansion to new markets, and development of high-impact medical products. The first Indian company to launch an emergency haemostat for trauma care, Axio ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here